echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Cell: Chinese scientists have revealed for the first time the lung adenocarcinoma molecule Panorama CellPress dialogue scientist.

    Cell: Chinese scientists have revealed for the first time the lung adenocarcinoma molecule Panorama CellPress dialogue scientist.

    • Last Update: 2020-07-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Click on the blue word above to pay attention to CellPress cell science, life science Life science lung cancer is the highest incidence rate and mortality rate in China and the world.in China, there are more than 700000 lung cancer cases and more than 600000 deaths every year in China.lung adenocarcinoma is the main pathological type of non-small cell lung cancer, accounting for about half of all lung cancer.compared with other pathological types of lung cancer, the proportion of non-smokers in lung adenocarcinoma is significantly higher, and the pathogenesis is complex.early detection, early diagnosis and early treatment of lung adenocarcinoma are of great significance for improving the prognosis of patients.protein is the direct executor of all life functions, and almost the target of all drugs.the systematic study of all protein characteristics in biological samples, such as cells and tissues, has gradually become one of the core contents of biomedical research.therefore, it is of great scientific significance to draw a panoramic protein molecular map of lung adenocarcinoma population for in-depth understanding of the pathological mechanism of lung adenocarcinoma, the discovery of biomarkers for disease diagnosis and drug treatment targets, as well as the realization of more accurate molecular typing of lung adenocarcinoma and the formulation of treatment plans.on July 9, 2020, cell, a journal of cell press cell publishing house, published online a large-scale proteomic sketch of clinical lung adenocarcinoma completed by Chinese scientists.in this study, the research team of Tan Minjia, Shanghai Institute of medicine, Chinese Academy of Sciences, together with Academician he Fuchu and Wang Yi from Academy of military medicine, National Center for Protein Science (Beijing), National Cancer Center / Chinese Academy of Medical Sciences Cancer Hospital Cheng Shujun and Xiao Ting, and Professor Li Jing of Shanghai Jiaotong University For the first time in the world, the team has carried out a large-scale, high-throughput and systematic panoramic proteomics study on lung adenocarcinoma.▲
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.